Eosin Y Sodium
CAS 17372-87-1
Eosin Y Sodium (CAS 17372-87-1) is a pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 10157.85 nM | 2 | - |
| Protein arginine N-methyltransferase 1 Enzyme |
IC50 | 6 | - | Homo sapiens |
| RmtA Enzyme |
IC50 | 4.74 | - | Emericella nidulans |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Eosin Y Sodium used for in pharmaceutical contexts?
Eosin Y Sodium (CAS 17372-87-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Eosin Y Sodium?
No adverse-event association or SIDER side-effect rows are rendered for Eosin Y Sodium in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Eosin Y Sodium also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Eosin Y (D&C Red No. 22) with EU status "permitted".
What clinical phase is Eosin Y Sodium in?
No phase 1-4 clinical development badge is rendered for Eosin Y Sodium because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Eosin Y Sodium?
Eosin Y Sodium has 3 bioactivity rows in this page query. Rendered target entries include Protein arginine N-methyltransferase 1, RmtA.